Activation of Deoxyribonuclease I by Nicotinamide as a New Strategy to Attenuate Tetracycline-Resistant Biofilms of Cutibacterium acnes
TLDR
In this paper, the effects of topical nicotinamide (NAM) on biofilms of C. acnes have been investigated using both in vitro and in vivo approaches, and the results showed that NAM potentiated the efficacy of suboptimal dosing of tetracycline against C., acnes.Abstract:
Biofilms of Cutibacterium (C.) acnes (formerly Propionibacterium acnes) are responsible for the persistence and antibiotic resistance of acne vulgaris. In addition to the standard treatments for acne vulgaris, a common adjunctive treatment is the topical administration of nicotinamide (NAM). However, the effects of NAM on biofilms of C. acnes have never been explored. This study comprehensively investigates the effects of NAM against biofilms of C. acnes using in vitro and in vivo approaches. The results showed that NAM potentiated the efficacy of suboptimal dosing of tetracycline against C. acnes. Moreover, NAM alone decreased the formation and increased the degradation of biofilms in C. acnes. The antibiofilm effect of NAM against C. acnes was further enhanced in combination with deoxyribonuclease (DNase) I, an enzyme with known antibiofilm properties. The computational molecular docking, surface plasmon resonance analysis, and enzymatic kinetic assay demonstrated that NAM binds to DNase I and accelerated its reaction. In conclusion, NAM activates DNase I to attenuate biofilms of C. acnes. This offers valuable insights into the strategies against biofilms that are worth elaborating on in other biofilm-related chronic cutaneous infections in the future.read more
Citations
More filters
Journal ArticleDOI
Synthesis, computational analyses, antibacterial and antibiofilm properties of nicotinamide derivatives
Ayşe Hümeyra Taşkın Kafa,Gamze Tüzün,Elif Güney,Rukiye Aslan,Koray Sayin,Burak Tüzün,Hilmi Ataseven +6 more
Journal ArticleDOI
The Synergy between Pharmacological Regimens and Dermocosmetics and Its Impact on Adherence in Acne Treatment
Elena Araviiskaia,Alison Margaret Layton,J. L. Lopez Estebaranz,Falk Ochsendorf,Giuseppe Micali +4 more
TL;DR: Dermocosmetics as an adjunct to pharmacological regimens has the potential to improve clinical outcomes by increasing treatment adherence in patients with acne.
References
More filters
Journal ArticleDOI
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Garrett M. Morris,Ruth Huey,William Lindstrom,Michel F. Sanner,Richard K. Belew,David S. Goodsell,Arthur J. Olson +6 more
TL;DR: AutoDock4 incorporates limited flexibility in the receptor and its utility in analysis of covalently bound ligands is reported, using both a grid‐based docking method and a modification of the flexible sidechain technique.
Journal ArticleDOI
Biofilms: an emergent form of bacterial life.
Hans-Curt Flemming,Jost Wingender,Ulrich Szewzyk,Peter D. Steinberg,Scott A. Rice,Staffan Kjelleberg +5 more
TL;DR: The fundamental role of the biofilm matrix is considered, describing how the characteristic features of biofilms — such as social cooperation, resource capture and enhanced survival of exposure to antimicrobials — all rely on the structural and functional properties of the matrix.
Journal ArticleDOI
Extracellular DNA Required for Bacterial Biofilm Formation
TL;DR: Bacterial biofilms are structured communities of cells enclosed in self-produced hydrated polymeric matrix adherent to an inert or living surface that have inherent resistance to antibiotics and host immune attack.
Journal ArticleDOI
A modified microtiter-plate test for quantification of staphylococcal biofilm formation.
TL;DR: The modification of the standard microtiter-plate test by introduction of an additional step of decolorization by acetic acid seems to be a useful improvement of the technique.
Journal ArticleDOI
The clinical impact of bacterial biofilms
Niels Høiby,Oana Ciofu,Helle Krogh Johansen,Zhijun Song,Claus Moser,Peter Østrup Jensen,Søren Molin,Michael Givskov,Tim Tolker-Nielsen,Thomas Bjarnsholt +9 more
TL;DR: Bacterial biofilms are resistant to antibiotics, disinfectant chemicals and to phagocytosis and other components of the innate and adaptive inflammatory defense system of the body and they can be treated by chronic suppressive antibiotic therapy.